In a nutshell This study examined the effect of duration and different types of hormone therapy on the risk of developing type 2 diabetes in prostate cancer patients. Researchers concluded that the type and duration of hormone therapy significantly affected diabetes risk. Some background Hormone therapy is a common treatment used in prostate...
Read MoreTreatment(s) now being considered-Orchiectomy Posts on Medivizor
Should immunotherapy be administered before or after hormone therapy?
In a nutshell This study examined whether immunotherapy with sipuleucel-T (Provenge) shows a greater immune response if administered before or after androgen deprivation therapy (ADT). Authors present preliminary evidence of improved immune cell response when sipuleucel-T was administered first in patients with recurrent prostate cancer at high risk of...
Read MoreDifferent metabolic side effects across two forms of hormone therapy
In a nutshell This study compared early metabolic changes across different types of androgen deprivation therapy (ADT). Authors reported that some metabolic changes were more pronounced with pharmacological ADT compared to surgical ADT. Some background ADT is a type of hormone therapy commonly used to treat advanced prostate cancer. ADT targets...
Read MoreHormone therapy: a risk factor for stroke and heart attacks in patients with prostate cancer
In a nutshell This study examined the link between androgen-deprivation therapy (ADT) and risk for developing heart attack or stroke in patients with prostate cancer. Some background Prostate cancer cells often require androgen hormones (male sex hormones such as testosterone) to grow. ADT is intended to reduce the production of...
Read More
